Relevant bibliographies by topics / HNSC CANCER TREATMENT

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'HNSC CANCER TREATMENT'

Author: Grafiati
Published: 16 January 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HNSC CANCER TREATMENT.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HNSC CANCER TREATMENT"

1

Agee, Robert, Samuel Flashner, Masataka Shimonosono, Andres Klein-Szanto, and Hiroshi Nakagawa. "Abstract 3082: Leveraging 3D organoids to identify molecular changes underlying HNSC initiation and development." Cancer Research 82, no. 12_Supplement (2022): 3082. http://dx.doi.org/10.1158/1538-7445.am2022-3082.

Full text
Abstract:
Abstract Head and neck squamous cell carcinoma (HNSC) is a devastating disease accounting for 570,000 newly diagnosed cases and resulting in 344,000 deaths annually. HNSC arises from its histological precursor lesion, squamous dysplasia (HNSD); however, most patients are diagnosed with late-stage HNSC with no prior identification of pre-malignant disease. Earlier diagnosis and intervention could ameliorate the outsized burden of HNSC; therefore, there is an urgent unmet need to characterize the molecular changes underlying progression through HNSD to HNSC. To identify novel therapeutic targets
APA, Harvard, Vancouver, ISO, and other styles
2

Zhao, Yixuan, Xin Huang, Zewei Zhang, Haizhou Li, and Tao Zan. "The Long Noncoding Transcript HNSCAT1 Activates KRT80 and Triggers Therapeutic Efficacy in Head and Neck Squamous Cell Carcinoma." Oxidative Medicine and Cellular Longevity 2022 (August 4, 2022): 1–19. http://dx.doi.org/10.1155/2022/4156966.

Full text
Abstract:
Head and neck squamous carcinoma (HNSC) is the most prevalent malignancy of the head and neck regions. Long noncoding RNAs (lncRNAs) are vital in tumorigenesis regulation. However, the role of lncRNAs in HNSC requires further exploration. Herein, through bioinformatic assays using The Cancer Genome Atlas (TCGA) datasets, rapid amplification of cDNA ends (RACE) assays, and RNA-FISH, we revealed that a novel cytoplasmic transcript, HNSC-associated transcript 1 (HNSCAT1, previously recognized as linc01269), was downregulated in tumor samples and advanced tumor stages and was also associated with
APA, Harvard, Vancouver, ISO, and other styles
3

Burkart, Sebastian, Christopher Weusthof, Karam Khorani, et al. "A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment." Cancers 15, no. 6 (2023): 1655. http://dx.doi.org/10.3390/cancers15061655.

Full text
Abstract:
Purpose: Identification of molecularly-defined cancer subgroups and targeting tumor-specific vulnerabilities have a strong potential to improve treatment response and patient outcomes but remain an unmet challenge of high clinical relevance, especially in head and neck squamous cell carcinoma (HNSC). Experimental design: We established a UCHL1-related gene set to identify and molecularly characterize a UCHL1-related subgroup within TCGA-HNSC by integrative analysis of multi-omics data. An extreme gradient boosting model was trained on TCGA-HNSC based on GSVA scores for gene sets of the MSigDB
APA, Harvard, Vancouver, ISO, and other styles
4

Haarmann, Mareike S., Philipp Zimmermann, Malte Suchan, Dominik Funken, Jens Peter Klußmann, and Johannes Brägelmann. "Abstract 3928: Analyzing treatment effects of chemo- and immunotherapy in the context of the TME in an ex vivo model of HNSC." Cancer Research 85, no. 8_Supplement_1 (2025): 3928. https://doi.org/10.1158/1538-7445.am2025-3928.

Full text
Abstract:
Abstract Head and neck squamous cell carcinoma (HNSC) accounts for 450.000 deaths worldwide each year. Rising cases of HNSC have been predicted. Understanding the tumor biology in patients is crucial to developing more efficient treatment strategies against HNSC. Especially in the context of immunotherapy, the interplay of immune, cancer and stroma cells in the tumor microenvironment (TME) strongly influences the biological characteristics and behavior of the tumor and its response to therapy. However, most HNSC in vitro models such as patient-derived cell lines and organoids do not recapitula
APA, Harvard, Vancouver, ISO, and other styles
5

Tang, Shouyi, Li Zhao, Xing-Bo Wu, et al. "Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas." Cancers 14, no. 16 (2022): 3986. http://dx.doi.org/10.3390/cancers14163986.

Full text
Abstract:
Head and neck squamous carcinoma (HNSC) is a frequent and deadly malignancy that is challenging to manage. The existing treatment options have considerable efficacy limitations. Hence, the identification of new therapeutic targets and the development of efficacious treatments are urgent needs. Cuproptosis, a non-apoptotic programmed cell death caused by excess copper, has only very recently been discovered. The present study investigated the prognostic importance of genes involved in cuproptosis through the mRNA expression data and related clinical information of HNSC patients downloaded from
APA, Harvard, Vancouver, ISO, and other styles
6

Cho, Sang Yeon, and Nam Sook Kang. "The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Head and Neck Squamous Cell Carcinoma." Cancers 16, no. 18 (2024): 3226. http://dx.doi.org/10.3390/cancers16183226.

Full text
Abstract:
Background: Head and neck squamous cell carcinoma (HNSC) is the most prevalent cancer in the head and neck region, originating from the mucosal epithelium of the oral cavity, pharynx, and larynx. The solute carrier (SLC) transporter superfamily, consisting of over 400 proteins across 65 families, plays a crucial role in cellular functions and presents promising targets in precision oncology. This study aims to analyze the expression of SLC transporters in HNSC and their potential as biomarkers and therapeutic targets. Methods: We leveraged mRNA and protein expression data from The Cancer Genom
APA, Harvard, Vancouver, ISO, and other styles
7

Pradhan, Sultan, and Arsheed Hussain Hakeem. "Management of Head and Neck Cancer: Surgical and Nonsurgical." An International Journal of Otorhinolaryngology Clinics 2, no. 1 (2010): 77–85. http://dx.doi.org/10.5005/jp-journals-10003-1020.

Full text
Abstract:
Abstract It is right time to review the management of head and neck squamous cancer (HNSC) because of fundamental changes in both diagnostic and therapeutic modalities. Head and neck cancer affects area highly associated with the individual's. identity and can produce profound alteration in appearance, speech, and swallowing. Due to morbidity, disfigurement and problems of disease control clinicians used to have lot of reservations in treating complex HNSC cases. The field has taken a new vigor by incorporating important basic advances in understanding of cancer, new modalities of treatment an
APA, Harvard, Vancouver, ISO, and other styles
8

Chen, Yin-Ju, Joseph T. Chang, Guo-Rung You, Chun-Yu Huang, Kang-Hsing Fan, and Ann-Joy Cheng. "Panel biomarkers associated with cancer invasion and prognostic prediction for head–neck cancer." Biomarkers in Medicine 15, no. 11 (2021): 861–77. http://dx.doi.org/10.2217/bmm-2021-0213.

Full text
Abstract:
Aim: Cell invasion leading to metastasis is a major cause of treatment failure in head–neck cancers (HNCs). Identifying prognostic molecules associated with invasiveness is imperative for clinical applications. Materials & methods: A systemic approach was used to globally survey invasion-related genes, including transcriptomic profiling, pathway analysis, data mining and prognostic assessment using TCGA-HNSC dataset. Results: Six functional pathways and six hub molecules (LAMA3, LAMC2, THBS1, IGF1R, PDGFB and TGFβ1) were identified that significantly contributed to cell invasion, leading t
APA, Harvard, Vancouver, ISO, and other styles
9

Park, Jun-Ook, Young Min Park, Woo-Jin Jeong, et al. "Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-Institutional Analysis of 1,033 Cases." Clinical and Experimental Otorhinolaryngology 14, no. 2 (2021): 225–34. http://dx.doi.org/10.21053/ceo.2020.01732.

Full text
Abstract:
Objectives. Head and neck squamous cell carcinomas (HNSCs) are frequently diagnosed at the locoregional advanced stage (stage IVa), but controversy remains regarding whether stage IVa HSNCs should be treated with upfront surgery or definitive chemoradiation therapy (CRT). The purpose of this study was to compare overall survival (OS) and disease-free survival (DFS) in patients with stage IVa HNSC treated primarily by surgery with curative intent with/without (neo)adjuvant treatment (surgery group) versus those treated primarily with CRT (CRT group).Methods. We reviewed data of 1,033 patients w
APA, Harvard, Vancouver, ISO, and other styles
10

Chuang, Yi-Hsuan, Chun-Yu Lin, Jih-Chin Lee, et al. "Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer." International Journal of Molecular Sciences 24, no. 17 (2023): 13068. http://dx.doi.org/10.3390/ijms241713068.

Full text
Abstract:
Head and neck squamous cell carcinoma (HNSC) exhibits genetic heterogeneity in etiologies, tumor sites, and biological processes, which significantly impact therapeutic strategies and prognosis. While the influence of human papillomavirus on clinical outcomes is established, the molecular subtypes determining additional treatment options for HNSC remain unclear and inconsistent. This study aims to identify distinct HNSC molecular subtypes to enhance diagnosis and prognosis accuracy. In this study, we collected three HNSC microarrays (n = 306) from the Gene Expression Omnibus (GEO), and HNSC RN
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HNSC CANCER TREATMENT"

1

Lee, June Young. "The Role of Noxa/MCL-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/3748.

Full text
Abstract:
Head and neck cancer is the sixth leading type of cancer with 90 percent of head and neck cancer arising from squamous cell lining on the epithelium of the oral and nasal cavity, pharynx, and salivary gland. Even with tremendous achievements on chemotherapeutic drugs and therapies, the long-term prognosis of patients with advanced head and neck squamous cell carcinoma (HNSCC) has shown little improvement over the last three decades. Cisplatin is one of widely used chemotherapeutic drugs for multiple cancers, including head and neck cancer, but the prolonged use of this drug is limited by its
APA, Harvard, Vancouver, ISO, and other styles
2

Shaikh, Mushfiq Hassan. "The Role of Human Papillomaviruses in the Aetiopathogenesis of Head and Neck Cancer in South Asia, and Approaches to Treatment." Thesis, Griffith University, 2017. http://hdl.handle.net/10072/366967.

Full text
Abstract:
Malignancies of the upper aero-digestive tract are a major public health problem, especially in South Asia. The major risk factors in South Asia remain smoked/smokeless tobacco, areca nut, alcohol abuse and poor diet, with limited evidence for human papillomavirus (HPV). Although HPV-associated head and neck squamous cell carcinoma (HNSCC) is well documented in the western world, studies on South Asian populations are few and inconsistent. However, the incidence of HPV-associated head and neck cancer (HNC) has increased in recent years. Certain high-risk types of HPV infection are regarded as
APA, Harvard, Vancouver, ISO, and other styles
3

KUMAR, SUNIL. "COMBINATORIAL THERAPY FOR TUMOR TREATMENT." Thesis, 2023. http://dspace.dtu.ac.in:8080/jspui/handle/repository/20430.

Full text
Abstract:
Cancer is a complex and multifaceted disease that continues to pose a significant challenge to global health. As the second leading cause of death worldwide. Early detection and noninvasive techniques of detecting cancer are necessary to improve treatment outcomes, save lives and improve the quality of life. Biopsies of tumors are often expensive and invasive and raise the risk of serious complications like infection, excessive bleeding, and puncture damage to nearby tissues and organs. Early detection biomarkers are often variably expressed in different patients and may even be bel
APA, Harvard, Vancouver, ISO, and other styles
4

Avinash, Pradhan Shalmali. "Identification of Therapeutic Targets for Oral Squamous Cell Carcinoma." Thesis, 2013. http://etd.iisc.ac.in/handle/2005/3324.

Full text
Abstract:
Oral squamous cell carcinoma (OSCC) is the most common head and neck cancer, with a worldwide incidence of 275,000 new cases annually (Warnakulasuriya, 2009). Globally, the head and neck carcinoma represents a major cause of morbidity and mortality and is the sixth most commonly occurring cancer (Warnakulasuriya, 2009). A majority (>90%) of the head and neck cancers are squamous in origin and thus are linguistically referred to as head and neck squamous cell carcinoma (HNSCC) (Warnakulasuriya, 2009). HNSCC includes cancers of the oral cavity, larynx and pharynx; oral cancer being the most comm
APA, Harvard, Vancouver, ISO, and other styles
5

Avinash, Pradhan Shalmali. "Identification of Therapeutic Targets for Oral Squamous Cell Carcinoma." Thesis, 2013. http://etd.iisc.ernet.in/2005/3324.

Full text
Abstract:
Oral squamous cell carcinoma (OSCC) is the most common head and neck cancer, with a worldwide incidence of 275,000 new cases annually (Warnakulasuriya, 2009). Globally, the head and neck carcinoma represents a major cause of morbidity and mortality and is the sixth most commonly occurring cancer (Warnakulasuriya, 2009). A majority (>90%) of the head and neck cancers are squamous in origin and thus are linguistically referred to as head and neck squamous cell carcinoma (HNSCC) (Warnakulasuriya, 2009). HNSCC includes cancers of the oral cavity, larynx and pharynx; oral cancer being the most comm
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "HNSC CANCER TREATMENT"

1

Caballero-Manrique, Esther, and Carlos A. Pino. Head and Neck Cancer Pain. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0026.

Full text
Abstract:
In the United States, there are 48,000 new cases of head and neck cancer (HNC) annually. Although HNC used to be associated mainly with smoking and drinking, it is now found in many nonsmokers and nondrinkers in their 50s due to the spread of HPV. Pain is typically present at the time of diagnosis. Treatment usually includes radiation, chemotherapy, and/or surgery, which address the mass effect and pain. Yet, patients continue to experience pain during and after treatment, because the treatment modalities can cause significant inflammation and neuropathy and can lead to central sensitization.
APA, Harvard, Vancouver, ISO, and other styles
2

Murphy, Barbara A., Lauren A. Zatarain, Anthony J. Cmelak, et al. Palliative issues in the care of patients with cancer of the head and neck. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0145.

Full text
Abstract:
Head and neck cancer (HNC) refers to tumours arising from the epithelial lining of the upper aerodigestive track, including the oral cavity, larynx, pharynx, paranasal sinuses, and salivary glands. There are 50,000 cases of HNC diagnosed annually within the United States. The majority of tumours (> 90%) are squamous cell carcinomas. Risk factors include tobacco, alcohol, and areca nuts; human papilloma virus (HPV) or Epstein-Barr virus; and mucosal irritation. Previously considered to be a disease of older adults, the epidemic of HPV-associated oropharyngeal cancers has led to a striking in
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "HNSC CANCER TREATMENT"

1

Chintakuntlawar, Ashish V., Hani Al-Halabi, and Aref Chehal. "Head and Neck Malignancies in the UAE." In Cancer Care in the United Arab Emirates. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-99-6794-0_31.

Full text
Abstract:
AbstractHead and neck squamous cell carcinomas (HNSCCs) are one of the most common malignancies in the world. In this chapter, we discuss the incidence, pathogenesis, treatment, and future challenges in the management of HNSCC in the United Arab Emirates. Tobacco, alcohol, betel nuts, chewing tobacco, and chronic irritation and inflammation of the mucosal surfaces lead to these cancers. Human papillomavirus-associated oropharyngeal cancers (HPV-OPSCCs) occur at a lower rate compared to the western hemisphere. Due to the unique demographics of the UAE, HNSCC is an important cancer to focus on w
APA, Harvard, Vancouver, ISO, and other styles
2

Eroglu, Imdat, Nuriye Ozdemir, and Ozan Yazici. "Immunotherapy in Brain, Head and Neck Cancer." In Immunotherapy in Human Cancers. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359388.11.

Full text
Abstract:
Besides immunotherapy, several other pathways are targeted in Head and Neck (HNC) for future treatment. HRAS, NTRK, MSI, NOTCH, and PIK3A are targetable pathways for HNC. Tipifarnib showed promising results in patients with HNC having HRAS mutation in phase 2 studies. Xevinapant, a potent oral inhibitor of the apoptosis proteins antagonist, is another novel molecule tested as a treatment option in HNC. A phase 2 trial showed that the addition of xevinapant to the CRT in locally advanced HNC results in very promising 5-yr OS benefits (53 % vs 28 %) compared to the CRT+placebo ( Multiomic studie
APA, Harvard, Vancouver, ISO, and other styles
3

Sanz-Garcia, Enrique, and Lillian L. Siu. "Targeting Molecular Residual Disease Using Novel Technologies and Clinical Trials Design in Head and Neck Squamous Cell Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23175-9_18.

Full text
Abstract:
AbstractHigh-risk human papillomavirus (HPV)-related and most cases of HPV-negative locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC) have substantial risks of relapse despite definitive therapy, and thus represent conditions of unmet clinical need. The ability now exists to detect molecular residual disease (MRD) in these patients post-definitive treatment such as surgery or (chemo)radiotherapy using novel and highly sensitive and specific technologies to measure cancer-derived circulating biomarkers. The positive and negative predictive values of these assays to foreca
APA, Harvard, Vancouver, ISO, and other styles
4

Tinhofer, Ingeborg. "The Role of Liquid Biopsies for Monitoring Disease Evolution." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_4.

Full text
Abstract:
AbstractBody fluids of cancer patients have attracted increasing attention in biomedical research within the last 15 years since—as so-called liquid biopsies—they represent a non-invasive source of clinically exploitable biomarkers, including circulating tumor cells (CTCs) and cell-free tumor DNA (ctDNA). Assessment of CTCs in peripheral blood from solid cancer patients has proven useful for detection of subclinical disease which otherwise remains invisible for current staging techniques. Based on results from large cohort studies in breast and colon cancer, diagnostic tests for enumeration of
APA, Harvard, Vancouver, ISO, and other styles
5

Budach, V., and A. Thieme. "Proton Therapy for Head and Neck Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23175-9_8.

Full text
Abstract:
AbstractTreatment of localized cancer with protons therapy (PT) seems an appealing alternative to photons. PT has been available for decades and has unique dose distribution properties with the so-called Bragg-peak enabling protons to stop after their maximum depth is reached within millimeters. PT allows sparing of normal tissues and organs to a much greater extent than photons, even when modern photon techniques like intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) are involved. Whereas IMRT and VMAT techniques have demonstrated their superiority to older 3
APA, Harvard, Vancouver, ISO, and other styles
6

Ruaro, Alessandra, Stefano Taboni, Marco Ferrari, and Piero Nicolai. "Managing the Internal Carotid Artery in Head and Neck Cancer: Where Are We?" In Critical Issues in Head and Neck Oncology. Springer Nature Switzerland, 2025. https://doi.org/10.1007/978-3-031-84539-0_10.

Full text
Abstract:
Abstract Carotid artery (CA) involvement in head and neck cancer (HNC) has a low incidence, occurring in 2–7% cases of advanced HNCs. Clinical scenarios can be various, with the CA being displaced, surrounded by the mass, or with its wall invaded in different degrees of depth. Magnetic resonance has proved to be a reliable tool in predicting CA invasion, although standardization in terms of radiological criteria that define CA involvement are lacking. Management of CA involvement has been historically debated in HNC, primarily due to the high risk of treatment-related complications, which are
APA, Harvard, Vancouver, ISO, and other styles
7

Bossi, Paolo, and Erika Stucchi. "Exercise and Nutrition Interventions in Head and Neck Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23175-9_21.

Full text
Abstract:
AbstractOverall Survival (OS) and late quality of life of patients with locally advanced, HPV-negative Head and Neck Squamous Cell Cancer (HNSCC) are not satisfactory. Nutritional status at the beginning of both surgical and non-surgical treatment with curative intent has been linked to OS and quality of life. Weight loss, body-mass index, functional parameters, and biochemical examinations have been associated with the risk of treatment-related adverse events, mortality, quality of life and outcome. Moreover, there is a strong need for effective preventive approaches that could be implemented
APA, Harvard, Vancouver, ISO, and other styles
8

Rischin, Danny. "Biomarkers for Immune Modulatory Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_6.

Full text
Abstract:
AbstractImmune checkpoint inhibitors have changed the standard of care for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, only a minority of patients respond, hence the search for predictive biomarkers. Potential predictive biomarkers for immune checkpoint inhibitors discussed in this chapter include (1) Immune checkpoint ligand expression e.g., PD-L1, (2) biomarkers of a T-cell inflamed tumour microenvironment (TME) such as gene expression profiles of activated T cells, (3) biomarkers of tumour neoepitope burden such as tumour mutation burden (TMB) and (4) mu
APA, Harvard, Vancouver, ISO, and other styles
9

Rieke, Damian T., and Ulrich Keilholz. "Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC." In HPV Infection in Head and Neck Cancer. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-43580-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rischin, Danny. "Update of Immune Therapies in Recurrent/Metastatic Head and Neck Cancer." In Critical Issues in Head and Neck Oncology. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_19.

Full text
Abstract:
AbstractSince the initial reports of activity of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), investigation of the role of immune therapies has been the major focus of clinical trials in R/M HNSCC. Randomised trials initially with nivolumab and later with pembrolizumab established overall survival benefit in patients with R/M HNSCC previously treated with platinum compared to physicians choice of 2nd line therapy, and have led to regulatory approval around the world. More recently the Keynote-048 trial has compared both pembrolizumab monotherapy and
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HNSC CANCER TREATMENT"

1

Altayeb, Yousra Bashir Fathalrhman, and Ecir Yılmaz. "Oral Squamous Cell Carcinoma (OSCC) Treatment by Magneti Nanoparticles (Hyperthermia Method): A Review." In 6th International Students Science Congress. Izmir International Guest Student Association, 2022. http://dx.doi.org/10.52460/issc.2022.020.

Full text
Abstract:
Squamous cell carcinoma (SCC) is the most commonly diagnosed oral cancer. It is a type of head and neck squamous cell carcinoma (HNSCC) oral cancer affects more than 300,000 people in a year. Oral cancer is the sixth most common malignant cancer. The traditional methods of treatment were used through surgery, followed by chemotherapy, but these methods are not effective enough for the treatment, so treatment was focused on using magnetic nanoparticles. Magnetic nanoparticles demolish only the cancer cells directly without affecting healthy cells. They can also be used to increase the effective
APA, Harvard, Vancouver, ISO, and other styles
2

Myers, Jeffrey. "Abstract IA08: Personalizing HNSCC treatment based on TP53 mutational status." In Abstracts: AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; April 23-25, 2017; San Diego, CA. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1557-3265.aacrahns17-ia08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sivakumar, Vinithagowry, Sebastian Waßenberg, Stefan Mattheis, Stephan Lang, Timon Hussain, and Cornelius Kürten. "Pre-treatment anemia affects head and neck cancer (HNC) patients overall survival." In 95th Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery e. V., Bonn. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1784644.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Batista M. R. B., Lidia Rebolho, Pamela Angelique Kuhlmann, Matias Eliseo Melendez, et al. "Abstract A34: SNPs as predictors in the tailoring of treatment for HNSCC patients undergoing organ preservation protocols." In Abstracts: AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; São Paulo, Brazil. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.tcm17-a34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Scheckenbach, Kathrin, Florian Paul Steffan, Corinna Haist, et al. "Combination of CAR-T cell therapy and BITEs as an optimized treatment strategy for head and neck cancer (HNSCC)." In 94th Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery e.V., Bonn. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1767276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Büntzel, J., S. Baumann, and T. Giesen. "Chlorin-E6-based photodynamic therapy (PDT) and photodiagnosis (PD) in the palliative treatment of head neck cancer (HNC)." In Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1685972.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'HNSC CANCER TREATMENT' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography